Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Campath, calcineurin inhibitor reduction, and chronic allograft nephropathy (the 3C Study) - results of a randomized controlled clinical trial.

Journal article

(2018), American journal of transplantation : official journal of the american society of transplantation and the american society of transplant surgeons, 18, 1424 - 1434

Increasing the use of mobile technology-derived endpoints in clinical trials.

Journal article

Herrington WG. et al, (2018), Clinical trials (london, england), 15, 313 - 315

Fibroblast Growth Factor-23 and Risks of Cardiovascular and Noncardiovascular Diseases: A Meta-Analysis.

Journal article

Marthi A. et al, (2018), Journal of the american society of nephrology : jasn

Declining comorbidity-adjusted mortality rates in English patients receiving maintenance renal replacement therapy.

Journal article

Storey BC. et al, (2018), Kidney international, 93, 1165 - 1174

Impact of CKD on Household Income.

Journal article

Morton RL. et al, (2018), Kidney international reports, 3, 610 - 618

Lowering LDL cholesterol reduces cardiovascular risk independently of presence of inflammation.

Journal article

Storey BC. et al, (2018), Kidney international, 93, 1000 - 1007

2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials.

Journal article

Hicks KA. et al, (2018), Journal of the american college of cardiology, 71, 1021 - 1034

A decade of the Clinical Trials Transformation Initiative: What have we accomplished? What have we learned?

Journal article

Tenaerts P. et al, (2018), Clinical trials (london, england), 15, 5 - 12

Impact of Apolipoprotein(a) Isoform Size on Lipoprotein(a) Lowering in the HPS2-THRIVE Study.

Journal article

Parish S. et al, (2018), Circulation. genomic and precision medicine, 11

2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials.

Journal article

Hicks KA. et al, (2018), Circulation, 137, 961 - 972

Prognostic utility of estimated albumin excretion rate in chronic kidney disease: results from the Study of Heart and Renal Protection.

Journal article

Mafham MM. et al, (2018), Nephrology, dialysis, transplantation : official publication of the european dialysis and transplant association - european renal association, 33, 257 - 264

A policy model of cardiovascular disease in moderate-to-advanced chronic kidney disease.

Journal article

Schlackow I. et al, (2017), Heart (british cardiac society), 103, 1880 - 1890

Randomized multicentre pilot study of sacubitril/valsartan versus irbesartan in patients with chronic kidney disease: United Kingdom Heart and Renal Protection (HARP)- III-rationale, trial design and baseline data.

Journal article

(2017), Nephrology, dialysis, transplantation : official publication of the european dialysis and transplant association - european renal association, 32, 2043 - 2051

Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease.

Journal article

Bowman L. et al, (2017), The new england journal of medicine, 377, 1217 - 1227

Biliary Tract and Liver Complications in Polycystic Kidney Disease.

Journal article

Judge PK. et al, (2017), Journal of the american society of nephrology : jasn, 28, 2738 - 2748

Load More +